CH3 BIOSYSTEMS — RESEARCH SPOTLIGHT | APRIL 2026
By Pranitha Bhuthkuri
A landmark 2026 study from the Weizmann Institute of Science uses our E0771 cells (SKU: 94A001)
murine breast adenocarcinoma cells to uncover a surprising mechanism by which metastatic cancer
evades cytotoxic T cells — with major implications for adoptive cell therapy.
Publication: Frontiers in Immunology, 2026 | Cell line: E0771 (SKU: 94A001) | Host strain: C57BL/6 (syngeneic)
